Nu Skin Enterprises (NYSE:NUS) Releases Quarterly Earnings Results, Meets Expectations

Nu Skin Enterprises (NYSE:NUSGet Free Report) announced its quarterly earnings data on Monday. The company reported $0.20 EPS for the quarter, meeting the consensus estimate of $0.20, FiscalAI reports. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. The firm had revenue of $320.11 million for the quarter, compared to the consensus estimate of $345.20 million. Nu Skin Enterprises updated its FY 2026 guidance to 0.700-0.900 EPS and its Q3 2026 guidance to 0.100-0.200 EPS.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

  • Second-quarter revenue was $320.1 million, including a $4 million foreign-currency headwind, while adjusted EPS was near the midpoint of guidance. Adjusted operating margin declined to 6.1% from 8.0% year over year.
  • Prysm iO adoption continued to build, with more than 39,000 devices placed—up nearly 30% quarter over quarter—and 2.5 million scans. Nu Skin expects 50,000–60,000 placements by year-end and plans to launch an AI-enabled app to improve personalization, conversion, and customer engagement.
  • Nu Skin delayed the formal India market launch to the first half of 2027 while it refines local manufacturing, logistics, technology integration, and the affiliate business model.
  • Management said recruiting and leadership development remain below the levels needed for sustainable growth, while affiliates are still adapting to selling the wellness-focused Prysm iO product rather than the company’s historically stronger beauty offerings.
  • Full-year guidance now calls for revenue of $1.28 billion–$1.35 billion and adjusted EPS of $0.70–$0.90. Reported results included a $78.9 million goodwill impairment and a $167.5 million deferred-tax valuation allowance, while the planned East-West restructuring is expected to incur $5 million–$10 million in cash transition costs.

Nu Skin Enterprises Price Performance

Shares of Nu Skin Enterprises stock traded down $0.33 on Monday, hitting $5.16. 1,116,925 shares of the company traded hands, compared to its average volume of 596,442. Nu Skin Enterprises has a 52 week low of $4.89 and a 52 week high of $14.62. The business has a 50-day simple moving average of $5.22 and a 200 day simple moving average of $6.98. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.34 and a current ratio of 2.03. The stock has a market capitalization of $250.52 million, a P/E ratio of 4.69 and a beta of 0.98.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Weiss Ratings lowered Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, June 4th. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce”.

View Our Latest Report on NUS

Hedge Funds Weigh In On Nu Skin Enterprises

Institutional investors have recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. grew its holdings in Nu Skin Enterprises by 22.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company’s stock valued at $25,222,000 after buying an additional 481,231 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Nu Skin Enterprises by 59.2% during the 4th quarter. AQR Capital Management LLC now owns 799,120 shares of the company’s stock worth $7,688,000 after acquiring an additional 297,071 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Nu Skin Enterprises by 1,167.2% during the 4th quarter. Millennium Management LLC now owns 275,100 shares of the company’s stock worth $2,646,000 after acquiring an additional 253,390 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Nu Skin Enterprises by 16.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,372 shares of the company’s stock worth $13,212,000 after acquiring an additional 193,987 shares in the last quarter. Finally, Bridgeway Capital Management LLC boosted its position in shares of Nu Skin Enterprises by 84.4% during the 3rd quarter. Bridgeway Capital Management LLC now owns 396,725 shares of the company’s stock valued at $4,836,000 after acquiring an additional 181,601 shares during the last quarter. 82.84% of the stock is owned by hedge funds and other institutional investors.

About Nu Skin Enterprises

(Get Free Report)

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

Featured Stories

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.